Static Chart Thiogenesis Therapeutics, Corp.

Stocks

Market Closed - Toronto S.E. 14:17:15 2026-10-23 EDT			5-day change	1st Jan Change
0.6200 ^CAD	+5.08%		+21.57%	-4.62%

09-22	Thiogenesis Therapeutics, Inc. Lists Phase 2 Clinical Trial to Pilot Study of TTI-0102 in Cystinosis	CI
08-06	Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Duration

Period